CALMARE THERAPEUTICS INC
CTTC · CUSIP 13126R102
2
institutional holders
161.6k
shares reported held*
$27.0kreported value*
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $0.17.
Holders, Q4 2019
| Manager | Shares | Change |
|---|---|---|
| WEYBOSSET RESEARCH & MANAGEMENT LLC 0.01% of their portfolio | 161.4k $27.0k | — |
| Private Capital Group, LLC 0.00% of their portfolio | 150 $0 | — |